ARCH Venture Fund VIII Overage, L.P.
Insider CIK 1617237 · UBX 10% owner · QTRX 10% owner · TWST 10% owner · MTCR 10% owner · SNNA 10% owner · CDAK 10% owner · FIXX 10% owner · NMRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 2,321,566 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | $1.50 | $7.50M | 8,854,098 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 1,036 | — | $0 | 1,889 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 1,034 | — | $0 | 1,888 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 176,920 | — | $0 | 1,214,770 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-24 | 2020-11-24 | 277,514 | — | $0 | 1,905,481 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 854 | — | $0 | 854 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 145,994 | — | $0 | 1,391,690 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 229,006 | — | $0 | 2,182,995 | SEC↗ |
| QTRX Quanterix Corp | J Other | 2020-11-20 | 2020-11-24 | 853 | — | $0 | 853 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 6,500,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 13,950,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 1,320,097 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 2,333,333 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 831,521 | — | $0 | 831,521 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 191,721 | — | $0 | 1,350,195 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 235,000 | $15.00 | $3.52M | 2,503,903 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 1,784,572 | — | $0 | 1,848,535 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 326,953 | — | $0 | 1,158,474 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 420,368 | — | $0 | 2,268,903 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 2,571,769 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 210,000 | $13.00 | $2.73M | 2,781,769 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 20,000 | $13.00 | $260.0K | 158,734 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 138,734 | — | $0 | 138,734 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 472,251 | — | $0 | 2,433,035 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,960,784 | — | $0 | 1,960,784 | SEC↗ |
| FIXX Homology Medicines, Inc. | J Other | 2019-05-21 | 2019-05-23 | 300,001 | — | $0 | 5,768,694 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion deriv | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 0 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 718,275 | — | $0 | 1,900,920 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 1,182,645 | — | $0 | 1,182,645 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 266,776 | — | $0 | 2,167,696 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 224,726 | — | $0 | 2,392,422 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 15,000 | $14.00 | $210.0K | 2,407,422 | SEC↗ |
| TWST Twist Bioscience Corp | C Conversion | 2018-11-02 | 2018-11-06 | 894,146 | — | $0 | 894,146 | SEC↗ |
| TWST Twist Bioscience Corp | P Buy | 2018-11-02 | 2018-11-06 | 60,000 | $14.00 | $840.0K | 954,146 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion deriv | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 0 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,067,160 | — | $0 | 8,365,764 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 1,486,745 | — | $0 | 1,486,745 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 195,672 | — | $0 | 1,682,417 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 4,228,432 | — | $0 | 6,298,604 | SEC↗ |
| UBX Unity Biotechnology, Inc. | C Conversion | 2018-05-07 | 2018-05-07 | 2,030,625 | — | $0 | 2,070,172 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 1,385,457 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 4,683,238 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 6,068,695 | — | $0 | 6,068,695 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 3,360,000 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 1,280,000 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 4,087,193 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 1,226,158 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 352,800 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | C Conversion deriv | 2017-12-11 | 2017-12-13 | 1,533,214 | — | $0 | 0 | SEC↗ |
| QTRX Quanterix Corp | P Buy | 2017-12-11 | 2017-12-13 | 266,000 | $15.00 | $3.99M | 1,537,684 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 1,271,684 | — | $0 | 1,271,684 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 381,507 | — | $0 | 2,412,001 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 109,769 | — | $0 | 2,030,494 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 477,042 | — | $0 | 1,920,725 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 1,045,426 | — | $0 | 1,443,683 | SEC↗ |
| QTRX Quanterix Corp | C Conversion | 2017-12-11 | 2017-12-13 | 398,257 | — | $0 | 398,257 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion deriv | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 0 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 319,421 | — | $0 | 882,493 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 563,072 | — | $0 | 563,072 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 211,934 | — | $0 | 2,750,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | C Conversion | 2017-08-01 | 2017-08-01 | 2,538,641 | — | $0 | 2,538,641 | SEC↗ |